Bulk Drug Manufacturing

Aventis Pharma to expand its bulk drug unit at Ankleshwar

Details: Category: Bulk Drug Manufacturing

Aventis Pharma to expand its bulk drug unit at Ankleshwar in Bharuch district in Gujarat with an investment of Rs. 890 million. The new unit will manufacture the following products

Sl. No	Name of product (Bulk-Drugs & Intermediates)	-	Existing Capacity (TPA)	Proposed Capacity (TPA)	Total Capacity (TPA)
1.	Pentoxifylline	Bulk drug	44	206	250
2.	Phenaramine Maleate	Bulk drug	72	38	100
3.	Frusemide	Bulk drug	60	80	140
4.	Ciclopiroxlamine	Bulk drug	0.167	-0.167	0
5.	Glibenclamide	Bulk drug	11	14	25
6.	Ramipril Substance	Bulk drug	0.3	-0.3	0
7.	Tonophosphan	Bulk drug	1	-1	0
8.	Articaine HCl	Bulk drug	22	8	30
9.	ACME (RP II 3)	Intermediate	28	7	35
10.	Phenoxypiretan	Intermediate	2	8	10
11.	Hydrochlorothiazide	Bulk drug	5	35	40
12.	Ketoprofen	Bulk drug	2	13	15
13.	ABAP	Intermediate	5	75	80
14.	Acebutolol	Bulk drug	0	25	25
15.	Buprenorphine HCl	Bulk drug	0	0.5	0.5
16.	TDPA	Intermediate	0	40	40
17.	TOTAL (Ton per annum)	Bulk drug & intermediate	252	538	791
18.	Pharma Formulations (Solid) mio tablets/annum		5577	0	5577

The company has proposed for change in product mix for future details are as given below:

Sl. No.	Name of product (Bulk-Drugs & Intermediates)	Proposed Capacity TPA	2008	2009	2010	2011	2012	2013
1.	Pentoxifylline	250	44	44	100	150	200	250
2.	Phenaramine Maleate	100	72	72	85	100	100	100
3.	Frusemide	140	60	60	100	140	140	140
4.	Ciclopiroxlamine	0	0	0	0	0	0	0
5.	Glibenclamide	25	11	11	15	20	25	25
6.	Ramipril Substance	0	0	0	0	0	0	0
7.	Tonophosphan	0	0	0	0	0	0	0
8.	Articaine	30	22	22	25	30	30	30
9.	ACME (RP II 3)	35	28	28	30	30	35	35
10.	Phenoxypiretan	10	2	2	4	6	8	10
11.	Hydrochlorothiazide	40	5	5	15	30	40	40
12.	Ketoprofen	15	2	2	2	5	10	15
13.	ABAP	80	5	5	10	10	50	80
14.	Acebutolol	25	0	0	5	10	20	25
15.	Buprenorphine	0.5	0	0	0	0.2	0.4	0.5
16.	TDPA	40	0	0	0	10	20	40
17.	TOTAL (Ton per annum)	791	251	251	391	541	678	791
18.	Pharma Formulation(Solid) mio tablets/annum	5577	5577	5577	5577	5577	5577	5577

Samrat Remedies to set up organic chemical unit at Vapi in Valsad

Details: Category: Bulk Drug Manufacturing

Samrat Remedies to set up organic chemical unit at Vapi in Valsad in Gujarat with an investment of Rs. 26.9 million.

The details of the proposed products are as given below:

Sr. No.	Product	Capacity TPM
[A]	INORGANIC CHEMICALS
1	Potassium Iodide	7.0
2	Sodium Iodide	7.0
3	Potassium Bromide	7.0
4	Potassium Meta periodate	1.0
5	Calcium Iodate	2.0
6	Sodium Meta Periodate	7.0
7	Copper Iodide	1.0
8	Iodine Pure	3.0
9	Hydro Iodic Acid	1.0
10	Iodine Mono Chloride	0.5
11	Potassium iodate	2.0
	Total Inorganic Chemicals	=SUM(ABOVE) 38.5
[B]	ORGANIC CHEMICALS
1	Methyl Iodide	5.0
2	Ethyl Iodide	1.0
3	Tri Methyl Sulphoxonium Iodide	7.0
4	Methyl Iodo Benzoate	2.0
5	Chloro Quinaldine	0.5
6	Di Iodo Salicylic Acid	0.5
	Total Organic Chemicals	16.0

Surya Life Sciences to set up bulk drug unit at Ankleshwar

Details: Category: Bulk Drug Manufacturing

Surya Life Sciences to set up bulk drug unit at Ankleshwar in Bharuch district of Gujarat with an investment of Rs. 45 million. The new unit will manufacture the following products with following capacities.

Sr. No.	Name of Product	Production Capacity (MTPM)
1.	Amlodipine Besilate	20
2.	Gabapentine HCl	30
3.	Glimipiride HCl	25
4.	Lamotrigine	30
5.	Lidocaine HCl	15
6.	Carbamezapine	30
7.	Phenyl propyl amine HCl	25
8.	Pioglitazone	5
9.	Phenyl Epherine HCl	5
10.	Quinine Sulphate	3
11.	Sertaline HCl	10
12.	Terbutaline Sulphate	20
13.	Venlafexine HCl	15
14.	Vitamin C	10
15.	Atorvastalin	5
16.	Letrozole	20
17.	Tramadol HCl	10
18.	Salbutamol Sulphate	5
19.	Meto prolol tartarate	10
20.	Meta phenoxy benzyl alcohol	30
21.	Para anisyl alcohol	50
22.	Phenanthrene	20
23.	Oxcarbazepine	20

Dayaram Health Care to expand its distillation plant and bulk drug unit at Ankleshwar

Details: Category: Bulk Drug Manufacturing

Dayaram Health Care to expand its distillation plant and bulk drug unit at Ankleshwar in Bharuch district of Gujarat with an investment of Rs. 3.5 million. The company is presently engaged in distillation of solvents with capacity of 260 MTPM. It is proposed to manufacture 156.55 MTPM of bulk drug intermediates. Total capacity after expansion will be 416.55 MTPM. Details of products along with their production capacity are given below:

Sr. No.	Name of Product	Existing Quantity (MTPM)	Proposed Quantity (MTPM)	Total Quantity (MTPM)
01	Thinner (Distillation)	30.00	Nil	30.00
02	Solvent HCl (Distillation)	100.00	Nil	100.00
03	Owned (Distillation)	65.00	Nil	65.00
04	Distillation product on job work	65.00	Nil	65.00
05	Chloropropionitrile (CLPN)	Nil	70.00	70.00
06	Chloropropionamide (CLPA)	Nil	48.00	48.00
07	Mono Methyl Amine. HCl (MMA)	Nil	20.25	20.25
08	Di Methyl Amine. HCl (DMA)	Nil	18.30	18.30
	Total	260.00	156.55	416.55